Tag: genetics

23andMe's Genetic Gamble: Bankruptcy as a Breeding Ground for Savvy Investors

23andMe's Genetic Gamble: Bankruptcy as a Breeding Ground for Savvy Investors

When news broke that 23andMe might be heading towards bankruptcy, it sent shockwaves through the investment landscape. A company that was once worth $6 billion, the sweetheart of the personalized medicine revolution, now on the verge of collapse. It’s tempting to interpret this as a cautionary tale, an indication that...

23andMe Seeks Sale Through Bankruptcy After Data Breach Settlement

23andMe Seeks Sale Through Bankruptcy After Data Breach Settlement

23andme, the consumer genomics company, is seeking protection under Chapter 11 bankruptcy laws. This move is merely another step in their scheme to sell the company. This decision comes on the heels of a March 2023 data breach that impacted 6.9 million customers and a buyout offer that was turned...